hPSC directed neural induction/NPC culture

• Use validated hPSC lines, defined neural induction medium, SB431542 for TGF-β/Activin/Nodal inhibition, Noggin or LDN193189/dorsomorphin for BMP-pathway inhibition, and Matrigel or another literature-used attachment substrate for adherent culture or replating of aggregates/rosettes.

• Use NPC expansion medium containing FGF2 and/or EGF only where the selected protocol reports NPC expansion under those mitogen conditions;
• Rosette-derived or hPSC-derived NPCs have been expanded as neural progenitors in published hPSC neural differentiation workflows.

• Use immunostaining antibodies or equivalent assays for pluripotency markers before induction, neural progenitor markers including PAX6, SOX1/SOX2, Nestin, and regional markers such as FOXG1 or dorsal telencephalic markers when cortical identity is intended;
• Neuronal differentiation can be assessed with neuronal markers and functional synapse/electrophysiology assays in extended cortical protocols.

• Use a humidified 37 °C, 5% CO₂ incubator, biosafety cabinet, phase-contrast microscope for colony, neural plate, rosette, and NPC morphology, low-attachment plates or AggreWell-style aggregate plates when using EB/aggregate induction, standard tissue-culture plates for adherent induction, centrifuge for cell handling, and fluorescence microscope or flow cytometer for marker analysis.

• Start with healthy, undifferentiated hPSCs and exclude cultures with obvious spontaneous differentiation before induction, because neural induction efficiency depends on the starting hPSC culture state and induction format.

• For adherent induction, plate hPSCs on an extracellular matrix substrate and initiate neural induction when cultures are at the density used by the selected protocol;
• Published dual-SMAD protocols report SB431542 at 10 µM with Noggin at 200 ng/mL or 500 ng/mL, and LDN193189 at 100 nM as a Noggin substitute in protocol literature.

• For aggregate/EB induction, generate hPSC aggregates, expose them to BMP inhibition alone or combined BMP/TGF-β-SMAD inhibition during neural induction, then plate aggregates and manually or enzymatically select neural rosettes when rosette structures appear.

• Replace hPSC maintenance medium with neural induction medium containing dual-SMAD inhibitors;
• Reported examples include SB431542 with Noggin or SB431542 with LDN193189/dorsomorphin, with induction commonly maintained through the early neural conversion window before rosette/NPC selection.

• Change medium according to the selected published protocol and monitor morphology for loss of compact pluripotent colony morphology and appearance of neural epithelial or rosette-like structures.

• Select neural rosettes or neural epithelial regions when present, because rosette selection was used to enrich neural progenitor populations in hPSC-derived NPC protocols.

• Plate selected rosettes/NPCs onto the substrate and culture them in NPC expansion conditions reported by the source protocol;
• Do not extend passage number or add patterning factors unless the specific protocol supports that change.

• Confirm NPC identity before downstream experiments by immunostaining or gene-expression analysis for neural progenitor markers such as PAX6, SOX1/SOX2, and Nestin, and assess regional identity when the intended output is cortical, dorsal telencephalic, mid/hindbrain, or another defined neural progenitor type.

Low PAX6/SOX1/Nestin-positive NPC yield:

• Possible cause: Starting culture condition, induction density, or induction format differs from validated conditions.
• Literature-supported solution: Return to a published dual-SMAD or rosette-selection protocol, use the reported inhibitor combination and timing, and verify marker expression before expansion.

Mixed or unstable regional identity:

• Possible cause is generic neural induction does not necessarily specify a single CNS territory.
• Literature-supported solution: Use a protocol designed for the intended regional identity, such as dorsal telencephalic/cortical NPC workflows, and verify regional markers instead of relying only on pan-NPC markers.

NPC purity differs between batches:

• Possible cause: Published comparisons show that EB/aggregate versus adherent induction, substrate, rosette isolation, and NPC expansion format can change yield and purity.
• Literature-supported solution: Standardize one published workflow across experiments and record the induction format, substrate, rosette isolation method, and expansion method for each batch.